Skip to main content

Imaging

#RA and MSK Ultrasound Dr. Eric Dein, a rheumatologist in Summit, NJ, discusses musculoskeletal ultrasound in rheumatoid arthritis as part of RheumNow's Hard Decisions in RA campaign. https://t.co/vMZVdL1jVM @ericdeinmd https://t.co/feAr77hVax

RheumNow Podcast – with Special Guest Dr. Janet Pope (9.8.2023)

Sep 08, 2023

This week, Dr. Jack Cush reviews the news with special guest, Dr. Janet Pope. They discuss "Not-non-Inferior", large scale genetic screening, Zoster risk w/ newer lupus drugs, tapering, RA referral problems and the TNR webinar session on "ORAL Surveillance Revisited".

Read Article
Study of 110 pts w/ LBP shows the Patrick-FABER test to be useful in addressing the SI jts & SpA diagnosis. It had sensitivity 76%, specificity 66%, PPV 58% & NPV 82%; & when (+) was assoc w/ inflammatory SI lesions on MRI & a SpA diagnosis https://t.co/EpisUSagO2 https://t.co/mt8XHIIprF

ICYMI: ACR Guidelines for Interstitial Lung Disease in Patients with Rheumatic Conditions

ACR
Sep 04, 2023

The American College of Rheumatology released summaries of two new guidelines for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Disease and for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic

Read Article

ACR Guidelines for Interstitial Lung Disease in Patients with Rheumatic Conditions

ACR
Aug 24, 2023

The American College of Rheumatology released summaries of two new guidelines for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Disease and for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic

Read Article

Fracture Risk Quantified for Older Spondyloarthritis Patients

MedPage Today
Aug 22, 2023

Medicare beneficiaries with ankylosing spondylitis (AS) incur frequent bone fractures, a new study indicated, with the risk boosted by some unsurprising factors but also including one that was not expected.



Fee-for-service Medicare claims data from 2016-2018 showed that AS patients

Read Article

Imaging Mass Cytometry to Study Lupus Nephritis

EurekaAlert!
Aug 17, 2023

Lupus researchers from the University of Houston are reporting the first use of the powerful imaging mass cytometry to examine the kidneys of patients with systemic lupus erythematosus, as a means of diagnosing lupus nephritis in SLE patients.  LN is a severe inflammation of the kidneys and a

Read Article

English for the Biologically-Challenged (8.4.2023)

Aug 04, 2023

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  This week highlights Veterans, Vegetarians and Antenatal Corticosteroids.

Read Article

2023 ACR/EULAR Criteria for Calcium Pyrophosphate Deposition Disease

Jul 27, 2023

The prevalence of radiographic chondrocalcinosis is estimated to be 4% to ≥10% in older adults, but the prevalence of symptomatic calcium pyrophosphate deposition (CPPD) disease is unknown. To advance our understanding of CPPD, the American College of Rheumatology and EULAR have published

Read Article
Belgian study of 312 PsA & 213 SpA pts showed that most had normal spinal Xrays (87.5% PsA, 92% SpA). SpA pts had higher mSASSS than PsA (p<0.05). More Cx (73%) than Lumbar (33%) in PsA; SpA, CX (64%) & LS (71%) evenly distributed https://t.co/Z8JRRuxmWZ https://t.co/8uMiAsk7aA

Anti-Drug Antibodies with Biologics (7.14.2023)

Jul 14, 2023

Dr. Jack Cush Reviews the news and journal reports on CVA, TKA, PJP, ADA, and more!

Read Article

ICYMI: 25 Great Women in Rheumatology

Jul 04, 2023

I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized? This was prompted by a smart article in Annals of Rheumatic Disease written by Drs. Tuhina Neogi (Boston) and Nicola Dalbeth (N. Zealand), entitled "Where are the women ‘

Read Article

2023 EULAR Recommendations on Imaging in Crystal-Induced Arthritis

Jun 19, 2023

New recommendations on imaging for crystal-induced (gout, CPPD) arthritis (CiA) were presented at EULAR 2023 in Milan. These included 5 overarching principles & 10 recommendations on the role of imaging in making a diagnosis, monitoring, predicting, guiding therapy, and patient education

Read Article

Diagnostic Yield of Cranial and Large Vessel Imaging in GCA

Jun 13, 2023

Combined cranial and large vessel ultrasound and PET/CT provided excellent accuracy for the diagnosis of giant cell arteritis (GCA).

Read Article

EULAR 2023 recommendation for imaging in large vessel vasculitis

Diagnosis of large vessel vasculitis can be challenging, and imaging modalities help with not only the diagnosis but sometimes in assessing flares in the disease. At EULAR 2023, recommendations for imaging modalities for large vessel vasculitis were discussed. These were evidence-based

Read Article

EULAR 2023 Notes from Milan (6.09.2023)

Jun 09, 2023

Dr. Jack Cush reviews highlight abstracts and sessions - covering lupus, RA, gout, Still's disease, safety data, AI in medicine and more - from last week's EULAR 2023 Congress held in Milan, Italy.

Read Article
Dual IL-17A/F inhibition with Bimekizumab reduced MRI inflammatory change in the SIJ and spine in AxSpA, and increasing proportion achieving MRI remission at Wk52, Abst#POS0246 #EULAR2023 @RheumNow https://t.co/w4VkkUklGl
The course of symptoms in CSA to RA showed greater severity in the ACPA+ group compared to the ACPA- group. This correlated with MRI-subclinical joint score, suggesting different underlying processes Khidir S Abst#POS319 #EULAR2023 @RheumNow https://t.co/C2ADAkkSM2
Late Breaker - EULAR 2023 update on imaging of large vessel vasculitis. Ultrasound is now recommended as first line imaging test in all patients with suspected GCA, and axillary arteries should be in the standard examination, Dejaco C et al, Abst#LB0009, #EULAR2023 @RheumNow https://t.co/ya41nJG6qK
2023 update @EULAR recommendations imaging in GCA What's new: 1. US = first line imaging test 2. Axillary arteries should be included in standard examination 3. Alternative imaging FDG-PET or MRI 4. Takayasu: MRI preferred CT or FDG-PET alternatives @Rheumnow #EULAR23 LB0008 https://t.co/rGPfOPX1gI
#EULAR2023 Clinical Highlights. SpA: OP0059 H2H RCT of SEC vs ADA Biosimilar in bDMARDs naive showed no difference in imaging progression at 2yrs. OP0061 Pooled analyses of UPA RCTs showed low rates of Extra-articular Manifestation. Numerically lower vs PBO for Uveitis @RheumNow https://t.co/GoUPfpwTLq
Key arguments for CSA skeptics: - definitions, imaging aren’t anywhere near as good as our own suspicion as clinicians is - we still struggle to prevent RA - it’s easy to go down a therapeutic slippery slope, and hard to track back - labels are hard to remove #EULAR2023 @RheumNow https://t.co/4adop3IR8g
Let le introduce you to ARTHUR 🤖 A very skilled robot who scans your hands and wrists in 15 mn 🤚 Amazing to see new #AI developments that will make our lifes’ easier! #EULAR23 @ROPCA3 @JustSoren Stand M6 @RheumNow https://t.co/7PtR2CGqTt

Better at Predicting RA from MRI: Humans or Computers?

Jun 01, 2023

An artificial intelligence model to assess pre-RA hand MRIs has confirmed what human readers have known before: that bone marrow edema and tenosynovitis are objectively the best predictors of future RA development in patients with clinically suspect arthralgias or undifferentiated arthritis

Read Article
Fluorescence optical imaging in early arthritis? Nice images but not ready for clinics yet Can not differentiate OA from RA & PsA SLE/SSc associated arthritis display a specific pattern, but usually auto-antibody profiles help w/ diagnosis OP0173 #EULAR23 @Rheunow https://t.co/bAMi9kDKS5
×